Advertisement
Advertisement
April 22, 2020
Cerus Endovascular’s Neqstent Coil-Assisted Flow Diverter Approved in Europe
April 22, 2020—Cerus Endovascular Ltd. announced that it has received European CE Mark approval for its Neqstent coil-assisted flow diverter device to treat intracranial aneurysms. Commercial sales, via a controlled market release across the European Union, are expected to begin during the fourth quarter of 2020.
According to the company, the Neqstent is designed to treat a range of aneurysm morphologies, including wide-necked bifurcation and bifurcation aneurysms. The adjunctive intrasaccular flow diverter device provides stable aneurysm neck coverage for the placement of embolization coils within the sac and long-term occlusion of the aneurysm.
The Neqstent is sized only to the aneurysm neck and designed for use in combination with embolization coils. The device maintains the coils inside the aneurysm sac without requiring parent vessel stabilization. Neqstent devices are constructed from a visible super-elastic mesh braid and are delivered and deployed in a similar manner as the Cerus Endovascular’s Contour neurovascular system, stated the company.
Advertisement
Advertisement
